Additional Bibliography of References

Select Broadcast Media Reports on Gardasil Vaccine

• Dec. 9, 2013. CBS-TV - The Doctors. HPV Vaccine Controversy.
• Aug. 19, 2009. “Gardasil Researcher Speaks Out,” a report by Sharyl Attkisson, CBS-TV.
• Feb. 6, 2009. Gardasil Vaccine Draws Concerns, a report by Sharyl Attkisson, CBS Evening News.
• Nov. 11, 2008. “One Mother’s Story & Bigger Questions About the U.S. Vaccine Safety System,” an investigate report by Jane Miller, WBAL-TV 11 (Baltimore).
• July 7, 2008. “Gardasil Concerns,” a report by Nancy Yamada, WUSA-TV (Washington, DC).
• February 13, 2007. “Should HPV Vaccine Be Mandatory?” Meredith Viera moderated debate with Nancy Snyderman, MD; Barbara Loe Fisher, NVIC President; Jessica Farrar, TX legislator. “Today Show,” NBC-TV.

Selected Print Media Reports

• Cluskey P. Sharp drop in number of Dutch teenage girls getting HPV vaccination. The Irish Times. Jun. 27, 2018.
• Sagonowsky E. Merck CEO: Gardasil plus pipeline equals big things ahead for vaccines. FiercePharma. Jun. 12, 2018
• Llamas M. Florida Mom Says HPV Vaccine Ruined Daughter’s Life. Drugwatch. May 15, 2018.
• Pulla, P. Understanding the HPV vaccine’s risk. The Hindu. Feb. 5, 2018.
• Joelving F. What the Gardasil Testing May Have Missed. Slate. Dec. 17, 2017.
• Cullen P. Almost 650 girls needed medical intervention after HPV vaccine. The Irish Times. Sep. 12, 2017.
• Guevara C. Class Action Lawsuit Against HPV Vaccine Filed in Colombia. Medscape. Aug. 7, 2017.
• Aoki, M. Suit opens in Tokyo court over cervical cancer vaccine side effects. The Japan Times Feb. 13, 2017
• Chustecka Z. Class Action Lawsuit Against HPV Vaccine Filed in Japan. Medscape. Jul. 27, 2016.
• Chustecka Z. Complaint Filed Over EMA's Handling of HPV Vaccine Safety Issues. Medscape. Jul. 5, 2016
• Chustecka Z. Case Reports of 'Syndrome' Appearing After HPV Vaccination. Medscape. Sep. 18, 2015
• Gallagher P. Thousands Of Teenage Girls Report Feeling Seriously Ill After Routine School Cancer Vaccination. The Independent. May 31, 2015.
• Dennis B.  Five pressing health priorities in 2014. Washington Post. Dec. 28, 2013.
• Sanofi sued in France over Gardasil vaccine. Reuters. Nov. 24, 2013. 
• Merck Press Release - Business Wire. Merck’s Investigational 9-Valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV types, in Phase III Study. Nov. 4, 2013.
• Baklinski T. Japan Withdraws Support of Controversial HPV Vaccine Over Safety Concerns. Lifesite News. Oct. 16, 2013.
• Mulcahy, N. Japan Withdraws HPV Vaccine Recommendation for Girls. Medscape. Jun. 25, 2013.
• Castillo M. Side effect fears stop parents from getting HPV vaccine for daughters. CBS News. Mar 18, 2013.
• Gonthier V. Family Sues After Teen Dies Following HPV Vaccination. Toronto Sun. Jan. 31, 2012.
• Green G. Gardasil: Krystal’s Story. Women Hurt by Medicine. May 14, 2010.
• People’s Daily Online. HPV vaccine comes under spotlight in S. Korea. Xinhuanet. Jun. 8, 2010.
• New Report Explores Gardasil Deaths.  Jun. 14, 2010. 
• Medical News Today. Cost-Effectiveness of HPV Vaccination in The Netherlands. July 4, 2009. 
• Scoop Independent News (NZ). Vaccine Roll-Out Is Wrong Without Honest Advice. Feb. 28, 2009. 
• Hart, B. “Gardasil Vaccine for boys?” Seattle Post Intelligencer . Jan. 16, 2009.
• “FDA Again Says No to Expanded Gardasil Use”. Wall Street Journal. Jan. 9, 2009.
• “New Gardasil cervical cancer vaccination requirements for immigrants stirs controversy”. NY Daily News. Oct. 24, 2008.
• “Merck Aims Gardasil to Women Least Likely to Benefit”. Bloomberg News. Oct.17, 2008. 
• “Study Questions Cost Effectiveness of Gardasil Cervical Cancer Vaccine”. Wall Street Journal. Aug. 21, 2008. 
• “Drug Makers Push Leads to Cancer Vaccine’s Rise. New York Times. Aug. 19, 2008. 
• Edelman S. Fed’s Warning Shot. New York Post. Jul. 6, 2008.
•  “My Girl Died as ‘Guinea Pig’ for Gardasil” New York Post. Jul. 20, 2008. 
• “Is HPV Vaccine To Blame for Teen’s Paralysis?” US News & World Report. Jul. 2, 2008. 
• “Judicial Watch Uncovers New FDA Records Detailing Ten New Deaths & 140 “Serious” Adverse Events Related to Gardasil.” Judicial Watch. June 30, 2008. 
• “Anti-Vaccine Activists vs. Gardasil”. Time Magazine. Jun. 19, 2008.
• December 6, 2007: Fox News — “28 Women Miscarry After Receiving HPV Vaccine Gardasil: FDA Says No Reason to Re-examine Approval.”
• “Merck Reaffirms 2007 Profit Outlook”. MSNBC. Dec. 4, 2007. 
• “Vaccines Give Merck Booster Shot.” TheStreet.com. Nov. 2, 2007. 
• “Merck Vaccine Should Be Required, Global, Experts Say” Bloomberg News. Sep. 21, 2007. 
• “HPV Vaccine Flags Need for More Pap Tests.” AlterNet.org. Sep. 7, 2007.   
• “Oral-Sex Cancer Link Suggests Boys Need Merck Vaccine”. Bloomberg News. Aug. 27, 2007. 
• Family Awaits News on Daughter’s Illness. The Record-Courier. May 23, 2007.  
• Dan Walters Column. Sacramento Bee. May 11, 2007. 
• UCSF Doctors Warn on Wide Use of Cervical Cancer Vaccine. San Francisco Chronicle. May 10, 2007. 
• “Merck posts 12% profit rise, affirms 2007 forecast”. Market Watch.  Apr. 19, 2007. 
• “VA set to Mandate Gardasil”. Boston Globe. Mar. 3, 2007. 
• Merck Stops Campaign to Mandate Gardasil Vaccine Use. Bloomberg News. Feb. 20, 2007. 
• Drugmaker Assists In Pushing for Mandate For HPV. Washington Post. Feb. 11, 2007. 
• Merck Gets First U.S. Cancer-Shot Mandate, From Texas. Bloomberg News. Feb. 2, 2007. 
• Letter to the Editor from Barbara Loe Fisher, “Risk, Racism and the HPV Vaccine”. Washington Post. Feb. 1, 2007. 
• “Force Is Not the Only Way to administer a Vaccine” by Courtland Milloy. Washington Post. Jan. 24, 2007. 
• D.C. Bill Would Mandate Vaccine. Washington Post. Jan. 10, 2007. 
• “A New Vaccine for Girls, But Should It Be Compulsory?” by Roni Rabin. New York Times. Jul. 18, 2006.

Selected Medical Literature Articles

• Shiller JT, Lowy DR. Papillomavirus-Like Particle Vaccines. J Natl Cancer Inst. Monogr 2000; 28: 50-54.
• Baylor NW, Egan W, Richman P. Aluminum salts in vaccines – US perspective. Vaccine 2002; May 31 20Supple 3: 518-523. 
• Burg EM. Human Papillomavirus and Cervical Cancer. Clin Microbiol Rev 2003; 16(1): 1-17.
• Haug CJ. Human Papillomavirus Vaccine: Reason for Caution. NEJM 2008; 359: 861-862.
• Slade BA, Leidel L, Vellozzi C, Woo EJ et al. Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine. JAMA 2009; 302(7): 750-757.
• Sutton I, Lahoria R et al. CNS Demyelination and Quadrivalent Vaccination. Mult Scler 2009; 15: 116-119.
• Rothman SM, Rothman DJ. Marketing HPV Vaccine: Implications for Adolescent Health and Medical Professionalism. JAMA 2009; 302(7): 781-786.
• Haug C. The Risks and Benefits of HPV Vaccination. JAMA 2009; 302(7): 795-796.
• Alvarex-Sonia MJ, Hernandez-Gonzalez A et al. Demyelinating Disease and Vaccination of the Human Papillomavirus. Rev Neurol 2011; 52(8): 472-476.
• Souayah N, Michas-Martin PA. Guillain Barre syndrome after Gardasil vaccination: data from Vaccine Adverse Events Reporting System 2006-2009. Vaccine 2011; 29(5) 886-889
• Klein NP, Hansen J et al. Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females. JAMA Pediatrics 2012; 166(12): 1140-1148.
• Soldevilla HF, Brones SFR, Navarra SV. Systemic lupus erythematosus following HPV immunization. Lupus 2012; 21: 158-161.
• Van Bogaert LJ. Are the currently existing anti-human papillomavirus vaccines appropriate for the developing world? AMHSR 2013; 3(3): 306-312.
• Pons-Salort M, Tiebault ACM et al. HPV genotype replacement: too early to tell. The Lancet Infectious Diseases 2013; 13(12): 1012.
• Arnheim-Dahlstrom L, Pasternak B et al. Autoimmune, neurologic, and venous thromboembolic adverse events after immunization of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ 2013; 347
• Mariani L, Venuti A. HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future. Journal of Translational Medicine 2010; 8:105.
• Colafranceso S Perricone C et al. Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of Autoimmune/Inflammatory Syndrome Induced by Adjuvants. American Journal of Reproductive Immunology 2013.
• Binagwaho A, Wagner CM et al. Achieving a high coverage in Rwanda’s national human papillomavirus programme. Bulletin of the World Health Organization 2012; 90: 623-28.
• Batson A, Meheus F, Brooke St. Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries. Vaccine 2006.
• Gupta S., Kerkar R A., et al. Is human papillomavirus vaccination likely to be a useful strategy in India? South Asian J Cancer. 2013 Oct-Dec; 2(4): 193–197.
• Tomljenovic, L., Colafrancesco, S., et al. Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccination as Part of the “Autoimmune/Auto-inflammatory Syndrome Induced by Adjuvants” Case Report and Literature Review. J Investig Med High Impact Case Rep. 2014 Jan-Mar; 2(1): 2324709614527812.
• Little, D.T., Ward, H.R., Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General Practice. J Investig Med High Impact Case Rep. 2014 Oct 28;2(4):2324709614556129
• Palmieri B, Piddighe D et al. Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature. Immunol Res 2017; 65(1): 106-116.
• Chandler RE, Juhlin K et al. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase. Drug Safety 2017; 40_ 81-90.
• Chandler, R.E. Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient? Drug Saf. 2017; 40(12): 1167–1170.
• Cervantes LJ, Doan AH. Discrepancies in the evaluation of the safety of the human papillomavirus vaccine. Mem Inst Oswaldo Cruz 2018; 113(8).
• Jørgensen L., Gøtzsche P.C., et al Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review. Syst Rev. 2018; 7: 8.

National Institutes of Health (NIH)

• Biological Therapies for Cancer
• Cancer Stat Fact Sheets (National Cancer Institute)

American Cancer Society

• American Cancer Society. Can Cervical Cancer Be Prevented? Nov. 1, 2017
• American Cancer Society. Key Statistics for Cervical Cancer Jan. 4, 2018   
• American Cancer Society. Key Statistics for Oral Cavity and Oropharyngeal Cancers Mar. 9, 2018 
• American Cancer Society. Key Statistics for Vaginal Cancer Mar. 19, 2018 
• American Cancer Society. Key Statistics for Penile Cancer Jun. 25, 2018 
• American Cancer Society. Key Statistics for Anal Cancer Jan. 4, 2018
• American Cancer Society. Key Statistics for Vulvar Cancer Jan. 16, 2018 
• American Cancer Society. HPV and Cancer - What is HPV? Oct. 9, 2017

IMPORTANT NOTE: NVIC encourages you to become fully informed about HPV and the HPV vaccine by reading all sections in the Table of Contents , which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.

« Return to Vaccines & Diseases Table of Contents